Cancer Prevention Pharmaceuticals
Tucson
About Cancer Prevention Pharmaceuticals
Cancer Prevention Pharmaceuticals, Inc. engages in the development and production of pharmaceutical agents to prevent cancers in people with elevated risk for these diseases in the United States. The company offers difluoro-methyl ornithine for clinical cancer prevention and treatment trials. It also develops diagnostic methods to identify individuals who are at high risk for specific cancers and medicine-related toxicities. In addition, the company develops cancer chemoprevention indications for common cancers along with prevention and therapeutic strategies in certain rare cancers. Cancer Prevention Pharmaceuticals, Inc. was incorporated in 2008 and is based in Tucson, Arizona.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $16.5M
- Funding stage: M&A
- Last round: Debt Financing (Jan 2021)
- Website: canprevent.com
- Phone: 5203341491
Industries & Categories
Biotechnology, Health Diagnostics, Therapeutics
Canonical: https://fsome.com/organization/cancer-prevention-pharmaceuticals-130669 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.